Docetaxel recalls

Docetaxel products have been recalled 5 times, most recently on 19 Jun 2024. The recalling company is usually Sagent Pharmaceuticals. The most common reason is particulate matter.

Total recalls5since 2018

Last 12 months0reported

Class I240% of total

Ongoing2latest 19 Jun 2024

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 2 40%Class II 3 60%Class III 0 0%

Why docetaxel is recalled

Companies

Product types

Injectable & IV Drugs5100%

By year

2024240%
2019120%
2018240%

Ongoing docetaxel recalls

2 active

Reported	Class	Recall	Company	Reason	Where
19 Jun 2024Drug	CLASS I	Docetaxel Injection, USP, 80 mg per (10 mg per mL) recalledDocetaxel	Sagent Pharmaceuticals	Particulate Matter	Nationwide
19 Jun 2024Drug	CLASS I	Docetaxel Injection, USP, 160 mg per (10 mg per mL) recalledDocetaxel	Sagent Pharmaceuticals	Particulate Matter	Nationwide

All docetaxel recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
19 Jun 2024Drug	CLASS I	Docetaxel Injection, USP, 80 mg per (10 mg per mL) recalledDocetaxel	Sagent Pharmaceuticals	Particulate Matter	Nationwide
19 Jun 2024Drug	CLASS I	Docetaxel Injection, USP, 160 mg per (10 mg per mL) recalledDocetaxel	Sagent Pharmaceuticals	Particulate Matter	Nationwide
20 Mar 2019Drug	CLASS II	Docetaxel Injection USP, 80 mg/, (20 mg/mL), One-Vial Formulation recalledDocetaxel	Dr. Reddy's Laboratories	Lead & Heavy Metals	Nationwide
9 May 2018Drug	CLASS II	Docetaxel injection concentrate, 20 mg/mL vial recalledDocetaxel	Sanofi-Aventis U.S	Potency & Assay	Nationwide
17 Jan 2018Drug	CLASS II	Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation recalledDocetaxel	Dr. Reddy's Laboratories	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.